HEPATOCELLULAR CANCER

This study looked at the safety of the drug Cabometyx in 263 Japanese people with a type of liver cancer called hepatocellular carcinoma. Participants took the drug as part of their normal care, and doctors watched for side effects over 12 months. The main goal was to see how oft…

This early-phase study tested a combination of two experimental drugs (vobramitamab duocarmazine and lorigerlimab) in 31 people with advanced solid tumors like prostate, melanoma, and pancreatic cancer. The main goal was to check safety and find the right dose. Participants recei…

This study tested whether adding hydroxychloroquine (a malaria drug) to the standard cancer drug sorafenib could better control advanced liver cancer. It included 64 adults whose cancer could not be cured by surgery or transplant. The goal was to see if the combination slowed tum…

This study explored whether a breath test could help find liver scarring (fibrosis), severe scarring (cirrhosis), or liver cancer early. Researchers collected breath samples from 56 adults with known or suspected liver problems. They used special machines to look for unique chemi…

This study looked at whether giving the pain medicine pregabalin before a liver cancer procedure (radiofrequency ablation) could lower pain after the procedure. 70 adults with liver cancer took part. The goal was to see if this approach improves pain control after treatment.